Molecular pathways in head and neck cancer: EGFR, PI3K, and more.


The treatment of head and neck squamous cell carcinoma (HNSCC) is set to undergo rapid changes, as novel treatment targets informed by genomic profiling and novel molecularly targeted therapies continue to make strides. In this review we provide an overview of the latest developments regarding (1) EGFR targeting for HNSCC, (2) PI3K as a novel treatment… (More)
DOI: 10.1200/EdBook_AM.2013.33.246


  • Presentations referencing similar topics